688506 (688506) News
Follow 688506 (688506) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
US drugmakers turn to China for licensing deals
Merck NYSE:MRK on Monday agreed to pay Chinese biotech SciBrunch Therapeutics $400 million upfront for global rights to an experimental cancer drug, making it the latest US drugmaker to license China-developed medicines.
GEOPOLITICS | Sep 28, 2026, 02:31 PM UTC
M
Sichuan Biokin reports H1 net loss of 1.6 billion yuan
Sichuan Biokin Pharmaceutical reported a H1 net loss of 1.6 billion yuan, per TradingView News.
EQUITY | Aug 26, 2026, 11:53 AM UTC